89 results
Page 4 of 5
8-K
EX-99.1
rxk1s
28 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
2tmx6z7 ta8qdtalhrjd
12 Jul 18
CytoDyn to Expand Strategic Focus with PRO 140 to Cancer and Immunologic Disorders
4:31pm
8-K
EX-4.1
1982s2w ie4f6
27 Jun 18
Entry into a Material Definitive Agreement
9:00am
8-K
EX-10.1
h1ao73497ac21v15ug0r
27 Jun 18
Entry into a Material Definitive Agreement
9:00am
8-K
EX-99.1
79v5u 02rmgcleh00tek
11 Oct 12
CytoDyn to Present Findings on its Feline Immunodeficiency
12:00am
8-K
EX-10.1
7szocq1 i7mj
30 Jul 12
Cytodyn Announces Entry into Agreement with Progenics Pharmaceuticals, Inc. to Acquire Pro 140
12:00am
8-K
EX-10.1
65p8twsfuk3sxo tvnr
11 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
j042vdz
13 Jan 12
Cytodyn Presenting Update on Its Therapeutic Antibody Programs at the Therapeutic Potential of Antibodies for Hiv Meeting In Boston, Ma
12:00am
8-K
ke3mf7kq9p92ip
16 Nov 11
Cytodyn Enters into Research Funding and Option Agreement with the Scripps Research Institute
12:00am
8-K
EX-99.1
tecsu4umizoum38
16 Nov 11
Cytodyn Enters into Research Funding and Option Agreement with the Scripps Research Institute
12:00am
10QSB
ocz5f321
16 Apr 07
Quarterly report (small business)
12:00am
8-K
EX-10.2
ivq6oy kijbw9
5 Feb 07
Entry into a Material Definitive Agreement
12:00am
10QSB
9wes672w 2u2009n
16 Jan 07
Quarterly report (small business)
12:00am